SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-21-001263
Filing Date
2021-10-01
Accepted
2021-10-01 16:30:52
Documents
1
Period of Report
2021-09-24

Document Format Files

Seq Description Document Type Size
1 jasper_fm3sep242021.html 3  
1 jasper_fm3sep242021.xml 3 4485
  Complete submission text file 0000905718-21-001263.txt   6119
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Reporting) CIK: 0001397144 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211299332

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)